Cardiogenics Holdings Inc (CGNH) Financial Statements (2025 and earlier)

Company Profile

Business Address 6865 SW 18TH STREET SUITE B13
BACA RATON, FL 33433
State of Incorp. NV
Fiscal Year End October 31
Industry (SIC) 7389 - Business Services, Not Elsewhere Classified (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments7126327
Cash and cash equivalent7126327
Receivables300
Prepaid expense and other current assets80
Income taxes receivable345
Other undisclosed current assets  10951
Total current assets:74376204
Noncurrent Assets
Property, plant and equipment435368
Intangible assets, net (including goodwill)108118110
Intangible assets, net (excluding goodwill)108118110
Other undisclosed noncurrent assets46  
Total noncurrent assets:196172178
TOTAL ASSETS:270548382
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,0211,050786
Other undisclosed accounts payable and accrued liabilities1,0211,050786
Debt72123
Derivative instruments and hedges, liabilities201100 
Other liabilities   0
Due to related parties131  
Other undisclosed current liabilities00100
Total current liabilities:1,4251,162889
Noncurrent Liabilities
Long-term debt and lease obligation  303 
Long-term debt, excluding current maturities  303 
Total noncurrent liabilities:  303 
Total liabilities:1,4251,465889
Equity
Equity, attributable to parent, including:(1,155)(561)(169)
Common stock111
Additional paid in capital46,50644,51442,036
Accumulated other comprehensive income (loss)(24)(118)(167)
Accumulated deficit(47,600)  
Other undisclosed equity, attributable to parent (38)(44,958)(42,039)
Equity, attributable to noncontrolling interest  (356)(338)
Total equity:(1,155)(917)(507)
TOTAL LIABILITIES AND EQUITY:270548382

Income Statement (P&L) ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
Revenues   1
Cost of revenue
(Cost of Product and Service Sold)
(70)  
Gross profit:(70) 1
Operating expenses(974)(2,527)(1,315)
Other undisclosed operating income70  
Operating loss:(974)(2,527)(1,314)
Nonoperating income (expense)(1,706)(410)3
Gain (loss), foreign currency transaction, before tax(7)719
Interest and debt expense(1,841)(300) 
Income (loss) from continuing operations:(4,521)(3,237)(1,311)
Income (loss) before gain (loss) on sale of properties:(4,521)(3,237)(1,311)
Other undisclosed net income (loss) 1,841300(6)
Net income (loss):(2,680)(2,937)(1,316)
Net income attributable to noncontrolling interest  188
Other undisclosed net loss attributable to parent   
Net loss available to common stockholders, diluted:(2,680)(2,919)(1,308)

Comprehensive Income ($ in thousands)

10/31/2015
10/31/2014
10/31/2013
10/31/2012
Net income (loss):(2,680)(2,937)(1,316)
Comprehensive income (loss):(2,680)(2,937)(1,316)
Comprehensive loss, net of tax, attributable to noncontrolling interest  (18)(8)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent9486 
Comprehensive loss, net of tax, attributable to parent:(2,586)(2,870)(1,325)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: